ArticleCureus2024
A Case of the Initial Presentation of Hemophagocytic Lymphohistiocytosis as Acute Unilateral Vision Loss.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Elaboration of a prognostic model associated with retinal hemorrhage in hemophagocytic lymphohistiocytosis.Annals of medicine · 2026Article
- Multimodal Imaging Features of Retinal Lesions in Hemophagocytic Lymphohistiocytosis: A Clinical Analysis.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is an incredibly rare disease that is characterized by the overproduction of histiocytes and lymphocytes, which then start to attack the body instead of just invasive pathogens. It has been known to affect many organs including most commonly blood cells and bone marrow, but it has also been known to affect the liver, spleen, skin, and the brain. Ocular involvement is rare and is mostly associated with HLH's effect on other body systems (i.e., HLH causes extremely low platelets which can lead to retinal hemorrhages). However, we discuss a case report of a 19-year-old man whose initial presentation of HLH was complete vision loss in one eye. MRI showed inflammation of the nerve which initially appeared similar to optic neuritis. Only after the patient began having systemic symptoms, as well as further lab tests, bone marrow biopsy, and imaging, were we able to make the diagnosis of HLH. This is the first reported case in the literature of a patient with HLH's initial presenting symptom being acute unilateral vision loss. This finding is important for the ophthalmic community to be aware of, both because HLH needs to be included in the differential for rare causes of unilateral complete vision loss especially when associated with systemic atypical symptoms such as fever or altered mental status, and because early recognition of HLH by ophthalmologists could lead to life-saving treatment. If undiagnosed and untreated, HLH can be fatal in months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.